9 results match your criteria: "Padm. Dr. D.Y. Patil Institute of Pharmaceutical Sciences & Research[Affiliation]"

Evaluation of Anti-inflammatory and Antimicrobial Activity of AHPL/AYCAP/0413 Capsule.

Pharmacognosy Res

January 2017

Manager - Analytical Department, R & D Center, Ari Healthcare Private Limited, Unit No. 401, International Biotech Park, BTS 2 Building, Chrysalis Enclave, 4 Floor, Plot No - 2A, MIDC Phase II, Hinjewadi, Pune, Maharashtra, India.

Background: Conventional therapeutic agents used for treatment of Acne are associated with various adverse effects necessitating development of safe and effective alternative therapeutic agents. In this context, a polyherbal formulation AHPL/AYCAP/0413 was developed for treatment of Acne.

Objectives: To evaluate Anti-inflammatory and antimicrobial activity of AHPL/AYCAP/0413.

View Article and Find Full Text PDF

Evaluation of anti-diabetic activity of AHPL/AYTAB/0513 tablet in streptozotocin induced diabetes in rats.

Int J Pharm Investig

January 2017

Ari Healthcare Private Limited, International Biotech Park, Hinjewadi, Pune, Maharashtra, India.

Background: Diabetes is a chronic, progressive disease associated with several complications leading to significant mortality and morbidity. Limitations and drawbacks of the conventional treatment generate need for safer, effective complimentary therapies to prevent complications, and maintain normoglycemic status.

Aim And Objectives: The aim of this study is to to evaluate antidiabetic activity of AHPL/AYTAB/0513 tablet alone, oral hypoglycemic agents (OHA[s]), and combination of AHPL/AYTAB/0513 tablet and OHA(s) in streptozotocin-induced diabetes in rats.

View Article and Find Full Text PDF

The present study reports protective effect of hydro-alcoholic extract of Luffa acutangula (HAELA) on doxorubicin (DXR) induced cardio and nephrotoxicity in mice by studying various serum biomarkers, antioxidants in target organs and histoarchitecture alterations. Pretreatment with HAELA reversed significantly the elevated serum biomarkers, alanine amino transferase, lactate dehydrogenase and creatinine phosphokinase in heart and kidney in DXR treated mice. In addition, HAELA treatment inhibited elevated malondialdehyde formation and restored the depleted glutathione, catalase, superoxide dismutase in heart and kidney tissue.

View Article and Find Full Text PDF
Article Synopsis
  • The study evaluated the neuroprotective effects of silymarin, piracetam, and protocatechuic acid ethyl ester (PCA) on cerebral global ischemic/reperfusion in a rat model.
  • The methods included a blockage of blood flow in the carotid arteries for 30 minutes followed by a 24-hour recovery period, during which various neurological and physiological functions were assessed.
  • Silymarin and PCA improved cognitive and motor functions, along with reducing brain damage, while piracetam showed some benefits but did not significantly enhance the body's natural defense systems.
View Article and Find Full Text PDF
Article Synopsis
  • A study was conducted on rats with focal ischemia to compare the neuroprotective effects of silymarin, piracetam, and protocatechuic acid ethyl ester (PCA).
  • Both silymarin (200 mg/kg) and PCA showed significant improvements in behavioral, biochemical, and histopathological outcomes, and they reduced brain water content and infarct size.
  • Silymarin was found to be more effective than both PCA and piracetam, particularly in restoring behavior and antioxidant levels during focal ischemia/reperfusion.
View Article and Find Full Text PDF

The dipeptidyl peptidase IV (DPP IV) enzyme is a novel target for the treatment of type 2 diabetes. Several DPP IV inhibitors are in the clinical development, since they are safe and tolerable with no increased risk of adverse events compared to placebo and have a low risk of hypoglycemia. They are flourishing as monotherapy and also in combination with commonly prescribed antidiabetic agents and are appropriate for once-daily oral dosing.

View Article and Find Full Text PDF

Hepatoprotective activity of hydroalcoholic extract of Luffa acutangula (HAELA) against carbon tetrachloride (CCl4) and rifampicin-induced hepatotoxicity in rats was evaluated and probable mechanism(s) of action has been suggested. Administration of standard drug- silymarin and HAELA showed significant hepatoprotection against CCl4 and rifampicin induced hepatotoxicity in rats. Hepatoprotective activity of HAELA was due to the decreased levels of serum marker enzymes viz.

View Article and Find Full Text PDF

In the present study, anti-inflammatory and analgesic effect of aqueous extract of Ficus bengalensis (AEFB) and methanolic extract of F. bengalensis (MEFB) was evaluated in animal models. Preliminary results indicated that MEFB treatment possesses significant anti-inflammatory potential as compared to AEFB.

View Article and Find Full Text PDF

Ethnopharmacological Relevance: The bark of Tectona grandis Linn. is traditionally used in the treatment of diabetes.

Aim: The present study was undertaken to investigate the effect of ethanolic extract of bark of Tectona grandis Linn.

View Article and Find Full Text PDF